on, okt 04, 2017 07:47 CET
The numbers during Q2 fell short of our estimates, both sales and profits. The most alarming in the report was the continued weakness in the visitor rate.
Read more and download the Research Update:
https://goo.gl/ckhJRe
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking.
https://www.redeye.se/